Epizyme, Inc. Insider Trading for August 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Epizyme, Inc. for August 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.14 | 3,740 | 131,420 | 2,825,396 | 2.8 M to 2.8 M (-0.13 %) |
| Aug 28 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.14 | 196,260 | 6,896,380 | 2,829,136 | 3 M to 2.8 M (-6.49 %) |
| Aug 28 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 35.14 | 3,740 | 131,420 | 2,825,396 | 2.8 M to 2.8 M (-0.13 %) |
| Aug 28 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 35.14 | 196,260 | 6,896,380 | 2,829,136 | 3 M to 2.8 M (-6.49 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 36.40 | 17 | 619 | 2,825,396 | 2.8 M to 2.8 M (0.00 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 36.40 | 883 | 32,144 | 2,825,413 | 2.8 M to 2.8 M (-0.03 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.13 | 3,723 | 130,801 | 2,826,296 | 2.8 M to 2.8 M (-0.13 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.13 | 195,377 | 6,864,239 | 2,830,019 | 3 M to 2.8 M (-6.46 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 32.46 | 2,394 | 77,707 | 3,025,396 | 3 M to 3 M (-0.08 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 32.46 | 125,606 | 4,077,058 | 3,027,790 | 3.2 M to 3 M (-3.98 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 33.04 | 723 | 23,884 | 3,153,396 | 3.2 M to 3.2 M (-0.02 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 33.04 | 37,943 | 1,253,455 | 3,154,119 | 3.2 M to 3.2 M (-1.19 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 36.40 | 17 | 619 | 2,825,396 | 2.8 M to 2.8 M (0.00 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 36.40 | 883 | 32,144 | 2,825,413 | 2.8 M to 2.8 M (-0.03 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 35.13 | 3,723 | 130,801 | 2,826,296 | 2.8 M to 2.8 M (-0.13 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 35.13 | 195,377 | 6,864,239 | 2,830,019 | 3 M to 2.8 M (-6.46 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 32.46 | 2,394 | 77,707 | 3,025,396 | 3 M to 3 M (-0.08 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 32.46 | 125,606 | 4,077,058 | 3,027,790 | 3.2 M to 3 M (-3.98 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 33.04 | 723 | 23,884 | 3,153,396 | 3.2 M to 3.2 M (-0.02 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 33.04 | 37,943 | 1,253,455 | 3,154,119 | 3.2 M to 3.2 M (-1.19 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 33.40 | 439 | 14,662 | 0 | -439 to 0 (-100.00 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 33.45 | 24 | 803 | 0 | -24 to 0 (-100.00 %) |
| Aug 25 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 33.45 | 24 | 803 | 0 | -24 to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 2,000 | 4,380 | 280,500 | |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 38.60 | 2,000 | 77,200 | 0 | 2 K to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 2,000 | 4,380 | 2,000 | 0 to 2 K |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 36.52 | 1,326 | 48,422 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 35.93 | 4,199 | 150,852 | 1,326 | 5.5 K to 1.3 K (-76.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 36.52 | 1,274 | 46,523 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 35.93 | 4,031 | 144,816 | 1,274 | 5.3 K to 1.3 K (-75.98 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | S | 35.93 | 325 | 11,676 | 0 | 325 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 325 | 0 | 325 | 0 to 325 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | S | 35.67 | 325 | 11,593 | 0 | 325 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 325 | 0 | 325 | 0 to 325 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRETT M JAMES | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | J | 0.00 | 374 | 0 | 374 | 0 to 374 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | J | 0.00 | 374 | 0 | 374 | 0 to 374 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BARRIS PETER J | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | S | 37.03 | 559 | 20,699 | 0 | 559 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | J | 0.00 | 559 | 0 | 559 | 0 to 559 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | BASKETT FOREST | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | S | 36.70 | 195 | 7,156 | 0 | 195 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | J | 0.00 | 195 | 0 | 195 | 0 to 195 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | S | 36.72 | 455 | 16,708 | 0 | 455 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | J | 0.00 | 455 | 0 | 455 | 0 to 455 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | DRANT RYAN D | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | J | 0.00 | 651 | 0 | 651 | 0 to 651 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KERINS PATRICK J | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 84 | 3,072 | 0 | 84 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 84 | 0 | 84 | 0 to 84 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 84 | 3,072 | 0 | 84 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 84 | 0 | 84 | 0 to 84 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 483 | 17,663 | 0 | 483 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 483 | 0 | 483 | 0 to 483 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 84 | 3,072 | 0 | 84 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 84 | 0 | 84 | 0 to 84 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 84 | 3,072 | 0 | 84 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 84 | 0 | 84 | 0 to 84 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | S | 36.57 | 483 | 17,663 | 0 | 483 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 483 | 0 | 483 | 0 to 483 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | KOLLURI KRISHNA KITTU | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 651 | 0 | 651 | 0 to 651 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Sell | S | 36.94 | 384 | 14,185 | 0 | 384 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Sell | S | 36.45 | 3,027 | 110,334 | 384 | 3.4 K to 384 (-88.74 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 3,411 | 0 | 3,411 | 0 to 3.4 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 651 | 0 | 651 | 0 to 651 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Sell | S | 35.56 | 433 | 15,396 | 0 | 433 to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 433 | 0 | 433 | 0 to 433 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 0.00 | 439 | 0 | 439 | 0 to 439 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 0.00 | 24 | 0 | 24 | 0 to 24 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 0.00 | 24 | 0 | 24 | 0 to 24 |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | Weller Harry R | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | NEA Partners 13, Limited Partn ... | 10% Owner | Sell | J | 0.00 | 12,900 | 0 | 0 | 12.9 K to 0 (-100.00 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | NEA Partners 13, Limited Partn ... | 10% Owner | Buy | J | 0.00 | 12,900 | 0 | 12,900 | 0 to 12.9 K |
| Aug 18 2014 | EPZM | Epizyme, Inc. | NEA Partners 13, Limited Partn ... | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 18 2014 | EPZM | Epizyme, Inc. | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Sell | J | 0.00 | 1,290,000 | 0 | 4,743,240 | 6 M to 4.7 M (-21.38 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 76,314 | |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 29.88 | 8,427 | 251,784 | 5,305 | 13.7 K to 5.3 K (-61.37 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 29.08 | 11,573 | 336,563 | 13,732 | 25.3 K to 13.7 K (-45.73 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 20,000 | 12,000 | 25,305 | 5.3 K to 25.3 K (+377.00 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.60 | 34,000 | 20,400 | 70,819 | |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 8,000 | 28,320 | 194,833 | |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 30.05 | 18,400 | 552,898 | 82,000 | 100.4 K to 82 K (-18.33 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 29.26 | 11,600 | 339,426 | 100,400 | 112 K to 100.4 K (-10.36 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.60 | 34,000 | 20,400 | 112,000 | 78 K to 112 K (+43.59 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 8,000 | 28,320 | 78,000 | 70 K to 78 K (+11.43 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 657,223 | |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 30.78 | 10,180 | 313,364 | 0 | 10.2 K to 0 (-100.00 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 29.96 | 19,820 | 593,892 | 10,180 | 30 K to 10.2 K (-66.07 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |